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Determination of the physiological 
and pathological roles of E2F3 in 
adult tissues
Ivonne Gamper1, Deborah L. Burkhart1, Megan J. Bywater1, Daniel Garcia2, Catherine H. 
Wilson1, Peter A. Kreuzaler1, Mark J. Arends3,5, Yao-Wu Zheng4,6, Alessandra Perfetto1,  
Trevor D. Littlewood1 & Gerard I. Evan1
While genetically engineered mice have made an enormous contribution towards the elucidation of 
human disease, it has hitherto not been possible to tune up or down the level of expression of any 
endogenous gene. Here we describe compound genetically modified mice in which expression of 
the endogenous E2f3 gene may be either reversibly elevated or repressed in adult animals by oral 
administration of tetracycline. This technology is, in principle, applicable to any endogenous gene, 
allowing direct determination of both elevated and reduced gene expression in physiological and 
pathological processes. Applying this switchable technology to the key cell cycle transcription factor 
E2F3, we demonstrate that elevated levels of E2F3 drive ectopic proliferation in multiple tissues. By 
contrast, E2F3 repression has minimal impact on tissue proliferation or homeostasis in the majority 
of contexts due to redundancy of adult function with E2F1 and E2F2. In the absence of E2F1 and 
E2F2, however, repression of E2F3 elicits profound reduction of proliferation in the hematopoietic 
compartments that is rapidly lethal in adult animals.
E2F3 is one of an eight-member family of transcription factors that are critical for cell cycle progression and dif-
ferentiation and are the principal targets of the RB tumour suppressor and its p107 and p130 siblings (reviewed in 
ref. 1). Within the E2F family, E2F1-3 are considered “activator E2Fs” whose principal function, once unleashed 
by hyperphosphorylation of RB in response to mitogenic signalling, is to engage expression of genes necessary 
for the G0-S cell cycle transition.
The three activator E2F transcription factors are believed to be broadly interchangeable and function-
ally redundant1–3 although various additional unique and often subtle properties have been attributed to each 
individual member. For example, germ-line and conditional, Cre-mediated deletions of E2f3 in vivo intimate 
that E2F3 has unique roles not shared with other activator E2F family members4, 5 during embryonic develop-
ment6, 7, in myogenic differentiation8, neuronal migration9, DNA damage responses10 and in some cancers such 
as HER2-driven mammary tumours11, 12, Ewing’s sarcoma and prostate cancer13. Moreover, whereas E2f1−/−, 
E2f2−/−, and E2f1−/−; E2f2−/− double knockout mice are all viable, exhibiting only subtle tumourigenic and devel-
opmental deficits1, deletion of E2f3 elicits profound embryonic lethality, principally due to dysfunctional cardiac 
development6. Such embryonic lethality, complete in a pure 129/Sv background, but still 75% penetrant in a 
mixed (129/Sv × C57BL/6) background, greatly complicates any genetic study of E2F3 function in adult tissues. 
Nonetheless, much of the biological output of E2F3 appears redundant with that of E2F1 and E2F2, and overall 
the most uniform detected phenotype of germ-line E2f3 deletion is partial reduction in proliferative activity in 
cultured cells14, 15.
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All germ-line and conditional E2f3 knock-out studies are complicated by the likelihood of developmental 
adaptation and compensatory rewiring during embryonic and tissue development and, in the case of conditional 
knock-outs, by incomplete deletion of the conditional allele, generating chimeric target tissues. Knock-out strat-
egies also suffer from the inherent limitation of their irreversibility, precluding investigation of the impact of, say, 
transient E2F3 ablation on normal or neoplastic tissue maintenance.
The other principal investigative strategy for studying the in vivo function of a protein is to express it ectopi-
cally in transgenic mice. In the case of E2F3, all such studies, whether keratin 5 promoter-driven in epidermis16, 
pro-opiomelanocortin-driven in pituitary17 or alphaA-crystallin promoter-driven in lens fibre cells18, concur that 
precocious expression of E2F3 elicits ectopic proliferation. Elevated E2F3 expression also increases apoptosis in 
epidermis and lens fibre cells16, 18. Unfortunately, such classical transgenic mice also suffer from inherent short-
comings: they are prone to variegated patterns and levels of transgene expression and to sporadic inactivation/
erosion of transgene expression due to promoter methylation and gene silencing. Furthermore, their pheno-
types ultimately depend as much on the biology of the specific promoter used to drive the E2f3 transgene as on 
E2F3 itself. Hence, while the collective data from the existing E2f3 knock-out and transgenic models all support 
the notion that E2f3 expression is critically involved in cell proliferation, development and cancer, the precise, 
real-time role of E2f3 in adult tissues in vivo remains unclear and is difficult to address with current experimental 
systems.
To circumvent the above issues, we generated a novel switchable gene expression mouse model that allows 
for tuneable expression (either elevated or repressed) of the endogenous E2f3 gene in adult mice. Importantly, 
in this model E2f3 is expressed normally during development, mitigating adaptive compensation for E2F3 loss 
during development but allowing E2F3 function in adults to be acutely and reversibly switched up or down, either 
systemically or tissue-by-tissue. Using this novel mouse, we directly determine the role of E2F3 in maintaining 
normal adult tissue architecture. Further, by combining our switchable E2f3 mouse with existing E2f1 and E2f2 
knockout animals, we constrain all classically mitogenic E2F1-3 activity to flow through our tuneable E2f3 allele. 
This allows us to address the impact of acute, transient repression of combined E2F1-3 function on normal tis-
sues, thereby exploring the potential existence of a temporal therapeutic window for inhibition of mitogenic E2Fs.
Results
To generate mice in which the endogenous E2f3 gene may be reversibly switched on or off at will, a heptameric 
tetracycline-response element (TRE) derived from the pTRE2 vector (Clontech) was targeted via homologous 
recombination to the promoter of the endogenous E2f3 locus in mouse embryonic stem cells (mESCs), from 
which E2f3TRE mice were derived. The TRE was placed in close proximity to the E2f3a promoter yet avoiding 
the critical Myc and E2F binding sites described previously19 (Fig. 1a). Insertion of this TRE then allows for 
ectopic control of E2f3 expression by serving as a binding site for tetracycline-regulatable transcriptional acti-
vators or repressors. Accordingly, E2f3TRE mice were then crossed into mice ubiquitously expressing the reverse 
tetracycline-dependent transactivator (rtTA), for reversible enforced endogenous E2f3 induction, or into mice 
ubiquitously expressing either the tTS(kid) tetracycline regulated transcriptional repressor or the reverse 
tetracycline-controlled transcriptional silencer (rtTS), both potentially enabling reversible repression of endog-
enous E2f3.
TRE insertion into the E2f3 promoter does not perturb normal E2f3 regulation. The great major-
ity of E2f3 knock-out mice die between E13.5 and P2 dpc20, exhibiting fatal cardiac abnormalities and typical 
signs of congestive heart failure. By contrast, homozygous E2f3TRE/TRE mice were born at expected Mendelian 
ratios, indicating that TRE insertion does not critically interfere with control of E2f3 expression during devel-
opment. In normal somatic cells, the kinetics and levels of E2f3 expression, specifically the E2f3a isoform, are 
tightly regulated in a cell cycle-dependent manner by multiple transcription factors, including Sp1, E2F and Myc 
families19. To assess any impact of the TRE insertion on normal E2f3 cell-cycle expression, quiescent wild-type 
and E2f3TRE/TRE MEFs were serum-stimulated and E2f3a expression monitored over time. Kinetics and levels of 
E2f3a expression were essentially identical in E2f3TRE/TRE and wild-type MEFs, in both cases peaking at 16 hours 
post serum-stimulation (Fig. 1b). We similarly saw no statistically significant differences in either E2f3a or E2f3b 
mRNA expression in adult E2f3TRE/TRE versus wild-type mouse spleen, lung, liver, or heart (Fig. 1c). Insertion of 
the TRE into the E2f3 promoter also had no discernible impact on the expression of genes located to either side 
of E2f3 on mouse chromosome 13 - Mboat1 (50 kb telomeric) and Cdkal1 (151 kb centromeric) - in the tissues 
examined, save for a modest decrease in the liver (Fig. 1d). Taken together, these data indicate that insertion of 
the 300 bp TRE into the E2f3 promoter has negligible impact on normal expression and regulation of either E2f3 
or its flanking genes.
Reversible induction of endogenous E2f3 in E2f3TRE/TREmice. To induce E2f3 ectopically from the 
endogenous E2f3TRE allele, we crossed E2f3TRE/TRE mice into the Rosa26rtTA*M2 background21, which ubiquitously 
expresses the reverse tetracycline-dependent transactivator (rtTA) driven from either one (Rosa26rtTA/+) or two 
alleles (Rosa26rtTA/rtTA) of the pan-active Rosa26 promoter (Fig. 2a). In the absence of doxycycline, both E2f3TRE/
TRE; Rosa26rtTA/+ and E2f3TRE/TRE; Rosa26rtTA/rtTA mice were born at normal Mendelian ratios and appeared indis-
tinguishable from their rtTA-negative control littermates (not shown). Administration of doxycycline to either 
E2f3TRE/TRE; Rosa26rtTA/+ or E2f3TRE/TRE; Rosa26rtTA/rtTA adult mice significantly increased E2f3 expression in all 
tested tissues within 3 days (Fig. 2b,c). Moreover, mice homozygous for the rtTA allele consistently expressed 1.4 
to 2.8 fold higher levels of E2f3 mRNA in their tissues relative to mice with a single rtTA allele. Hence, the extent 
of E2f3 over-expression in E2f3TRE/TRE; Rosa26rtTA mice is proportional to the level of rtTA expressed. Tissues of 
doxycycline-treated E2f3TRE/TRE; Rosa26rtTA/+ and E2f3TRE/TRE; Rosa26rtTA/rtTA mice over-expressed both E2F3a and 
E2F3b protein isoforms (Fig. 2c). By contrast, expression of the two genes flanking E2f3, Mboat and Cdkal1, was 
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unaffected by expression of rtTA combined with doxycycline administration (Supplementary Fig. 1). Induced 
over-expression of E2f3 was rapidly reversed upon withdrawal of doxycycline (Fig. 2d).
Reversible repression of endogenous E2f3 expression in E2f3TRE/TREmice. We used two comple-
mentary approaches to repress E2f3 expression. In the first, we crossed E2f3TRE/TRE mice to a transgenic strain 
that expresses the tetracycline regulated repressor, tTS22 driven from the broadly active β-actin promoter, as 
described previously23. tTS is a fusion protein combining the bacterial tet repressor (TetR) with the KRAB-AB 
domain of the Kid-1 transcriptional repressor. In the absence of antibiotic (tetracycline or doxycycline), tTS 
binds to its cognate TRE-element, whereupon it represses transcription of proximal genes (Fig. 3a). E2f3TRE/TRE; 
β-actin-tTS pups were born at normal Mendelian frequency from mothers administered with 100 mg/L doxycy-
cline throughout pregnancy to inactivate the tTS repressor (Fig. 3b). Furthermore normal levels of both E2F3a 
and b proteins were expressed in MEFs derived from embryos developed in the continuous presence of doxycy-
cline (Fig. 3c). By contrast, neither E2F3a nor E2F3b proteins was detectable in MEFs derived from embryos con-
tinuously deprived of doxycycline throughout development and cell culture (Fig. 3c). Moreover, no E2f3TRE/TRE; 
β-actin-tTS pups were born in the absence of doxycycline (Fig. 3b) and anatomical analysis of antibiotic-deprived 
Figure 1. TRE insertion into the E2f3 promoter does not affect normal E2f3 regulation. (a) Schematic of E2f3 
promoter with relative positions of known transcription factor binding sites, the transcription start site, and the 
TRE insertion site. Blue box- Myc binding site; green box- E2F binding site; grey box- E2f3a exon 1a; arrow- 
transcription start site; red box-TRE insertion site. (b) Quantitative RT-PCR analysis of E2f3a expression in 
quiescent wild type and E2f3TRE/TRE MEFs following serum stimulation. E2f3a expression is normalized to HPRT 
and data normalized to the quiescent sample within each genotype. n = 3 independent MEF lines; error bars, 
s.d. (c) Quantitative RT-PCR analysis of E2f3a and E2f3b mRNA expression in adult wild type and E2f3TRE/TRE 
mouse tissues. Expression is normalized to HPRT and relative to the mean of the wild type tissues. n = 3 mice; 
error bars, s.e.m. (d) Quantitative RT-PCR analysis of Mboat1 and Cdkal1 expression in adult wild type and 
E2f3TRE/TRE mouse tissues. Expression is normalized to actin and relative to the mean of the wild type samples. 
n = 3 mice; error bars, s.e.m. Two-tailed t-tests; Cdkal1: liver, **P = 0.004.
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E2f3TRE/TRE; β-actin-tTS embryos collected at E11.5 indicated the same severe reduction in heart trabeculation6 
(Supplementary Fig. 2) as that reported for germ-line E2f3 knock-out mice15, 20. Hence, E2f3TRE/TRE; β-actin-tTS 
embryos in the absence of doxycycline accurately replicate the developmental phenotype of germ-line E2f3 
knockout mice. Hence, doxycycline efficiently keeps the tTS repressor inactive, permitting normal developmen-
tal E2f3 expression.
Doxycycline, like other members of the tetracycline family of antibiotics, accumulates in developing bones24. 
Such accumulation serves as an antibiotic reservoir that delays its clearance after it is withdrawn from E2f3TRE/TRE; 
β-actin-tTS pups born to mothers previously treated with doxycycline throughout gestation and weaning (unpub-
lished observations and25, 26). To circumvent the impact of this delay on switchably repressing E2f3 expression in 
E2f3TRE/TRE mice, we replaced doxycycline with tetracycline, which is less lipophilic and has a shorter biological 
half-life27. Maintenance of pregnant mothers on drinking water containing tetracycline concentration at 50 mg/L 
proved sufficient to maintain normal embryonic development of E2f3TRE/TRE; β-actin-tTS pups (Fig. 3b) and cul-
minated in neonate and adult mice indistinguishable from their E2f3 wild-type littermates. This effective level of 
tetracycline was then used for all subsequent studies unless otherwise noted.
We next assessed the efficacy and reversibility of E2f3 repression in mouse tissues in vivo using the tTS sys-
tem. We first confirmed that administration of tetracycline throughout development maintains expression of 
Figure 2. E2f3 expression may be reversibly induced in E2f3TRE/TRE mice. (a) Schematic of rtTA driven 
expression from the E2f3TRE locus. Grey box- exon, blue box- TRE element, green oval- reverse tetracycline 
trans activator, orange triangle- doxycycline. (b) Quantitative RT-PCR analysis of E2f3 expression in adult 
control (n = 6(spleen, lung), n = 5(liver)), E2f3TRE/TRE; Rosa26rtTA/+ (n = 4) and E2f3TRE/TRE; Rosa26rtTA/rtTA (n = 3) 
mouse tissues following administration of doxycycline for three days. Expression is normalized to HPRT 
and relative to the mean of the control samples. Error bars, s.e.m. Two-way ANOVA with a Tukey’s multiple 
comparisons test; *P < 0.5, ***P < 0.001. (c) Immunoblot analysis of E2F3 protein levels in adult control, 
E2f3TRE/TRE; Rosa26rtTA/+ and E2f3TRE/TRERosa26rtTA/rtTA mouse tissues following administration of doxycycline 
for three days. Replicate samples are generated from tissues isolated from independent mice. Expression of 
GAPDH is included as a loading control. Refer to Supplementary Fig. 11 for full images. (d) Quantitative 
RT-PCR analysis of E2f3 expression in adult control (n = 3) and E2f3TRE/TRE; Rosa26rtTA/+ tissues isolated from 
mice following administration of doxycycline for three days only (+3, n = 2) or for three days with subsequent 
withdrawal for seven days (+3/−7, n = 5). Expression is normalized to HPRT and relative to the mean of the 
control samples. Error bars, s.e.m. Two-tailed t-test: control vs. +3/−7, P = 0.82 (spleen), 0.10 (liver), 0.52 
(lung); n.s., not significant. Control genotypes include E2f3TRE/TRE in the presence and absence of doxycycline 
and E2f3TRE/TRE; Rosa26rtTA/+ and E2f3TRE/TRERosa26rtTA/rtTA maintained in the absence of doxycycline.
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Figure 3. E2f3 expression may be reversibly repressed in E2f3TRE/TRE mice. (a) Schematic of tTS(kid)-driven 
repression. Grey box- exon, blue box- TRE element, red oval- tetracycline regulated repressor, orange triangle- 
doxycycline. (b) Genotypes of live births from E2f3TRE/TRE; β-actin-tTS crosses maintained on normal drinking 
water (H2O), with doxycycline (dox), or with tetracycline (tetra). Chi-square test, ***P < 0.0001 (water), 
0.85(dox), 0.04*(tetra). ns = not significant. (c) Immunoblot analysis of E2F3 protein levels in E2f3TRE/TRE (−) 
and E2f3TRE/TRE; β-actin-tTS (+) cultured mouse embryonic fibroblasts, developed and maintained either in 
the presence (dox) or absence (untreated) of doxycycline. Replicate samples represent independently isolated 
embryo cultures. GAPDH is included as a loading control. Refer to Supplementary Fig. 12 for full images. (d) 
Immunoblot analysis of E2F3 protein levels in adult control E2f3TRE/TRE and E2f3TRE/TRE; β-actin-tTS tissues 
isolated from mice maintained on tetracycline. Replicate samples are generated from tissues isolated from 
independent mice. GAPDH is included as a loading control, *non-specific band. Refer to Supplementary Fig. 13 
for full images. (e) Quantitative RT-PCR analysis of E2f3 expression in E2f3TRE/TRE; β-actin-tTS mice maintained 
on tetracycline (n = 3) or following 1 (n = 4) or 2 (n = 3) weeks withdrawal of tetracycline. Expression is 
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E2f3 at ostensibly normal levels in all tested adult tissues (Fig. 3d). However, withdrawal of tetracycline from 
adult mice hitherto maintained on tetracycline induced ubiquitous and profound repression of E2f3, evident 
within one week and thereafter sustained (Fig. 3e), with concomitant reduction of both E2F3a and E2F3b proteins 
(Fig. 3f). Expression of E2f3’s two neighbouring genes, Mboat1 and Cdkal1, was unaffected except for a modest 
decrease in Cdkal1 in spleen (Supplementary Fig. 3). Subsequent restoration of tetracycline to the drinking water 
of E2f3-repressed E2f3TRE/TRE; β-actin-tTS mice rapidly restored normal E2f3 expression (Fig. 3f).
We also reconfigured the tTS repression system from one where tetracycline inactivates the repressor to one 
where the antibiotic activates it. Such a configuration has clear advantages in situations requiring long periods 
of normal E2f3 expression punctuated by acute periods of E2f3 repression. To do this, we generated a novel 
Rosa26CAG-rtTS strain that ubiquitously expresses a chimeric protein formed from the fusion of the reverse tetracy-
cline regulated region of rtTA28 with the robust transcriptional silencer derived from the KRAB domain of Kid-1 
protein22, 29, 30, similar to the one previously described31. The resulting rtTS repressor is dependent on tetracycline 
or doxycycline for its repressing activity (Fig. 3g). Administration of doxycycline to E2f3TRE/TRE; Rosa26CAG-rtTS/+ 
mice for one week repressed E2f3 transcription to nearly undetectable levels in all tissues tested; this repression 
was reversible upon withdrawal of doxycycline (Fig. 3h). Together these two systems, tTS and rtTS, allow for 
unprecedentedly rapid and flexible switching of target gene activity in adult tissues in vivo.
Consequences of differential expression of E2F3 in adult tissues. Because switchable genetic sys-
tems obviate the complications of both embryonic lethality and adaptive compensation induced by absence or 
constitutive over-expression of genes during development, we could uniquely use our switchable E2f3TRE/TRE mice 
specifically to determine the biological functions of E2F3 in adult tissues in mice that had developed in the pres-
ence of normal E2F3 expression.
Consistent with its role in driving cell cycle, enforced expression of endogenous E2f3 in E2f3TRE/TRE; Rosa26rtTA/rtTA 
mice induced known E2F3 target genes, Ccna1, Cdc2, and E2f1 (Fig. 4a) in all tissues examined (spleen, liver, 
and lung). Increased proliferation (Ki67- or p-H3-positive cells) was clearly evident within 3 days of enforced 
E2f3 expression (Fig. 4b,c) in two relatively quiescent adult tissues, lung and liver while in spleen, which is 
already highly proliferative, a modest increase was also evident. The increase in proliferation, which was rtTA 
level-dependent (i.e. greater in 2 rtTA alleles versus 1) (Fig. 4c), is consistent with the increase in prolifera-
tion induced by classical transgenic over-expression of ectopic E2f3 expression in other mouse models16–18, 32. 
Interestingly, E2F3-induced proliferation in liver initially peaked and then fell back to a lower, although still ele-
vated, level that was thereafter sustained for at least 60 days, so long as E2f3 induction was maintained (Fig. 4d). 
Similarly, peripheral leukocyte populations showed a trend towards a transient increase immediately follow-
ing ectopic E2f3 expression (Supplementary Fig. 4). Hence, acute induction of enforced E2f3 expression drives 
ectopic proliferation in multiple somatic tissues of adult mice.
By contrast, systemic repression of E2f3 for one or two weeks in adult mice had no discernible impact on 
the proliferative indices of any tested tissues, including constitutively proliferating tissues such as small intes-
tine, spleen and thymus (Fig. 5a). Likewise, expression of the common E2f target genes Ccna1, Cdc2 or E2f1 in 
multiple tissues was unperturbed by E2F3 repression (Supplementary Fig. 5). Furthermore, long-term systemic 
repression of E2f3, over many weeks, had no discernible impact on the health of animals, whose tissues remained 
histopathologically indistinguishable from those of wild-type controls (data not shown). These data are consist-
ent with the notion that the function of E2F3 in adult tissue homeostasis is largely dispensable, presumably due 
to functional redundancy with other activator E2F family members3, 5, 33. To determine whether such functional 
redundancy remains sufficient to compensate for a lack of E2F3 activity under conditions of increased prolifer-
ative burden, we assessed the impact of E2F3 repression in acutely regenerating tissues. We saw no measurable 
inhibitory impact of E2F3 repression on liver regeneration after CCl4 injury or intestinal crypt regeneration after 
radiation injury (Fig. 5b,c). By contrast, mammary gland expansion and elaboration in pregnant mice was signif-
icantly retarded, as evidenced by decreased proliferation and reduced terminal budding (Fig. 5d). We conclude 
that, while E2F3 clearly contributes to the proliferative capacity of normal proliferating and regenerating tissues, 
its repression in most adult tissues can be complemented by alternate mechanisms – presumably E2F1 and E2F2 
– even in extremis (see below).
Determining real-time dependency on activator E2F activity in adult tissues in vivo. The com-
mon transcriptional activity of the three mitogenic E2Fs is essential for somatic cell cycle progression and prolif-
eration of diverse cell types7, 33–36. However, the redundant functionalities of the mitogenic E2Fs - E2F1, E2F2, and 
normalized to HPRT and relative to the mean of the samples maintained on tetracycline. Error bars, s.e.m. One-
way ANOVA with a Tukey’s multiple comparisons test, ***P < 0.001. (f) Immunoblot analysis of E2F3 protein 
levels in E2f3TRE/TRE; β-actin-tTS mice maintained on tetracycline throughout (0), removed from tetracycline 
for 2 weeks (−2), or removed from tetracycline for 2 weeks followed by re-addition of tetracycline for 1 week 
(−2/+1) or 2 weeks (−2/+2). Replicate samples are generated from tissues isolated from independent mice. 
GAPDH is included as a loading control. Refer to Supplementary Fig. 14 for full images. (g) Schematic of rtTS 
driven repression. Grey box- exon, blue box- TRE element, red oval- reverse tetracycline trans silencer, orange 
triangle- doxycycline. (h) Quantitative RT-PCR analysis of E2f3 in control E2f3TRE/TRE (n = 12 (spleen, liver), 11 
(lung)) and E2f3TRE/TRE; Rosa26CAGrtTS/+ mouse tissues in the presence of 2 g/L doxycycline for seven days ( + 7, 
n = 5) or for seven days and a subsequent seven days post withdrawal ( + 7/−7, n = 4). Expression is normalized 
to HPRT and relative to the mean of the control samples. Error bars, s.e.m. One-way ANOVA with a Tukey’s 
multiple comparisons test, **P < 0.01, ***P < 0.001, n.s. = not significant.
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E2F3 - obscure the impact of blocking any individual member (see above and ref. 4, 5), necessitating inhibition of 
all three to understand their shared role in vivo. Unfortunately, E2f1-3 triple knock-out mice display embryonic 
lethality, as well as aberrant dynamics in multiple embryonic tissues – most notably, constitutively high levels 
of apoptosis34, 36, 37 – which precludes meaningful analysis of their shared role in adult tissue homeostasis and 
pathology. Therefore, to determine directly the role of global E2F1-3 activity in adult mice, we generated E2f1−/−; 
E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice in which, due to deficiency of E2F1 and E2F2, all activator E2F function is 
funnelled through the regulatable E2f3 gene.
E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice maintained on tetracycline (tet repressor inactive) were grossly 
and histopathologically indistinguishable from control E2f1−/−; E2f2−/−; E2f3TRE/TRE animals (data not shown) and 
exhibited similar life-spans (median survival: 172.5 and 159 days, respectively). However, withdrawal of tetracy-
cline (tet repressor active) rapidly triggered profound pathologies. By three weeks post tetracycline withdrawal, 
E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice exhibited severe leukopenia and thrombocytopenia (Fig. 6a). 
Correlating with these reduced hematopoietic cell numbers in the periphery, reduced proliferation was evident in 
the bone marrow, spleen, and thymus (Fig. 6c) and reduced cellularity was observed in the bone marrow (Fig. 6d). 
The three main hematopoietic populations of the bone marrow – B-cells, T-cells, and myeloid cells – were all 
markedly reduced by three weeks post tetracycline withdrawal (Supplementary Fig. 6). At this time, the internal 
structures and relative geographical locations of differentiated cell populations within the spleen remained similar 
in both E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice and appropriate controls (Supplementary Fig. 7), but both 
the spleen and thymus appear macroscopically smaller in E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice than 
Figure 4. Consequences of acute E2f3 induction in adult tissues. (a) Quantitative RT-PCR analysis of E2f1, 
Cdc2 and CyclinA in adult control (n = 5 (spleen, lung), n = 4 (liver)) and E2f3TRE/TRE; Rosa26rtTA/rtTA (n = 3) 
mouse tissues following administration of doxycycline for three days. Expression is normalized to HPRT and 
relative to the mean of the control samples within each tissue. Error bars, s.e.m. Two-tailed t-test; control vs 
rtTA/rtTA: **P = 0.01 (CyclinA, liver), 0.05* (Cdc2, liver), 0.05* (E2f1, spleen). (b) Immunohistochemical 
staining of phosphorylated histone 3 (p-H3) in the spleen and Ki67 in the liver and lung of control and 
E2f3TRE/TRE; Rosa26rtTA/rtTA mice following administration of doxycycline for three days. Scale bar 100 µm. (c) 
Quantification of p-H3 positive nuclei per field of view of the spleen (red pulp) or Ki67 positive nuclei per field 
of view in the liver (hepatocytes) and lung isolated from control (n = 5(spleen, lung), n = 9(liver)), E2f3TRE/TRE; 
Rosa26rtTA/+ (n = 3(spleen), n = 4(liver, lung)) and E2f3TRE/TRE; Rosa26rtTA/rtTA (n = 4(spleen, lung), n = 3(liver)) 
mice following administration of doxycycline for three days. Mean of 5 images per mouse; error bars, s.e.m. 
Mann-Whitney test; control vs. rtTA/+, *P = 0.03 (liver); control vs. rtTA/rtTA, ***P = 0.005 (liver), 
0.03* (lung). (d) Quantification of Ki67 positive nuclei per field of view in liver (hepatocytes) isolated from 
control (n = 9) and E2f3TRE/TRE; Rosa26rtTA/rtTA mice after 3 (n = 3) or 60 (n = 5) days continuous doxycycline 
administration. Mean of 5 images per mouse; error bars, s.e.m. Control and rtTA/rtTA quantifications from 
panel C are included for comparison. Mann-Whitney test; control vs. 60days, **P = 0.005. Controls for 
(a–d) include E2f3TRE/TRE on and off doxycycline and E2f3TRE/TRE; Rosa26rtTA/+ and E2f3TRE/TRE; Rosa26rtTA/rtTA 
maintained in the absence of doxycycline.
www.nature.com/scientificreports/
8SCIenTIfIC REPORTS | 7: 9932  | DOI:10.1038/s41598-017-09494-6
their controls (data not shown). By five weeks’ post tetracycline withdrawal, all mice were moribund and severely 
cytopenic, including erythrocytopenia (Fig. 6b and Supplementary Fig. 8). In the small intestine, acute repression 
of E2f3 in E2f1/2 doubly-deficient mice triggered a progressive increase in enteroendocrine cells and decrease in 
goblet and Paneth cells (Fig. 6e and Supplementary Fig. 9). Repression of E2f3 in E2f1−/−; E2f2−/− doubly defi-
cient mice had no discernible impact on non-proliferating tissues such as liver, lung and kidney (data not shown). 
Hence, acute and long-term homeostatic dependency on functional E2F1-3 is restricted to proliferative organs 
and most marked in hematopoietic tissues.
Given the dramatic and rapidly lethal impact of E2f1-3 repression in E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS 
mice, we next asked whether expeditious reversal of E2f3 repression could reverse the blood and intestinal pheno-
types and preserve viability. Indeed, re-administration of tetracycline to leukopenic E2f1−/−; E2f2−/−; E2f3TRE/TRE; 
β-actin-tTS mice deprived of tetracycline for two weeks rapidly and completely reversed both cytopenic and intes-
tinal phenotypes, leading to full recovery (Fig. 7a,b and Supplementary Fig. 9). By contrast, re-administration of 
tetracycline to near moribund E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice deprived of tetracycline for three 
weeks failed to rescue the animals (data not shown). These data define a tight temporal window during which 
E2F1-3-deprived mice can recover if E2F function is restored.
Discussion
We describe a novel class of switchable genetic mouse model, using the E2f3 gene as an exemplar, which allows 
for reversible up or down regulation of an endogenous gene in adult mice at will. Such regulation is achieved 
by inserting a TRE into the endogenous E2f3 promoter, allowing external modulation of the endogenous E2f3 
gene via either a tetracycline-dependent transcriptional activator (rtTA) or a tetracycline-dependent repres-
sor tTS(kid) or rtTS. Insertion of the TRE by itself has no significant effect on the normal regulation of E2f3 
aside from a very mild decrease of E2f3 expression in the livers of E2f3TRE/TRE mice. Nonetheless, there is an 
Figure 5. Consequences of E2f3 repression in adult tissues. (a) Quantification of p-H3 positive nuclei per 
intestinal crypt or field of view of spleen and thymus in control E2f3TRE/TRE; βactin-tTS mice maintained on 
50 mg/L tetracycline and control E2f3TRE/TRE mice and E2f3-repressed E2f3TRE/TRE; β-actin-tTS mice following 
1 or 2 weeks withdrawal of tetracycline. n = 4 mice, mean of 5 images per mouse; error bars, s.e.m. Mann-
Whitney test; P = 0.63(intestine), 0.23(spleen), 0.83(thymus). (b) Quantification of hepatocytes with BrdU 
positive nuclei per field of view in control (n = 8) and E2f3TRE/TRE; β-actin-tTS (n = 6) mice maintained in the 
absence of tetracycline for a minimum of 3 weeks (off tetra) and 3 days post induction of liver damage with 
CCl4. Mean of 5 images per mouse; error bars, s.e.m. Mann-Whitney test; P = 0.48. (c) Intestinal regeneration 
was calculated by counting the number of viable crypts and multiplying that by the average size of the 
regenerating crypts50 in control E2f3TRE/TRE and E2f3TRE/TRE; β-actin-tTS mice several weeks post withdrawal of 
tetracycline (off tetra) and 3 days post exposure to 14 Gy of ionizing radiation. n = 4 mice, mean of 5 images per 
mouse; error bars, s.e.m. Mann-Whitney test; P = 0.34. (d) Quantification of p-H3 positive nuclei per unit area 
of epithelial cells in mid-gestation (E10.5) E2f3TRE/TRE and E2f3TRE/TRE; β-actin-tTS mice maintained for several 
weeks in the absence of tetracycline. n = 3 mice, mean of 5 images per mouse; error bars, s.e.m. Mann-Whitney 
test; *P = 0.03. Quantification of the number of terminal end buds per 5x field collected from mid-gestation 
(E10.5) E2f3TRE/TRE and E2f3TRE/TRE; β-actin-tTS mice maintained for several weeks in the absence of tetracycline. 
n = 3 mice, mean of 3–5 images per mouse. Two-tailed t-test; *P value = 0.03. Controls for (a–d) include 
E2f3TRE/TRE both on and off tetracycline and E2f3TRE/TRE; β-actin-tTS mice maintained on 50 mg/L tetracycline.
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Figure 6. Repression of E2f3 in the absence of E2f1 and E2f2 is rapidly lethal in adult mice. (a) Histogram 
of erythrocytes, leukocytes, and platelets in E2f1−/−; E2f2−/−; E2f3TRE/TRE control (n = 8) and E2f1−/−; 
E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice following withdrawal of 100 mg/L tetracycline for 1 (−1, n = 3), 2 (−2, 
n = 3(erythrocytes), n = 2(leukocytes, platelets)) or 3 (−3, n = 5(erythrocytes, platelets), n = 4(leukocytes)) 
weeks. Error bars, s.e.m. Student’s two-tailed t-test; control vs. -2weeks, **P = 0.007 (platelets); control vs. 
-3weeks, *P = 0.027 (leukocytes); control vs. -3weeks, ***P < 0.0001 (platelets). (b) Survival curve of E2f1−/−; 
E2f2−/−; E2f3TRE/TRE control (n = 18) and E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice maintained in the 
presence of tetracycline (+tetra, n = 10) or following removal of tetracycline (off tetra, n = 13). Log-rank 
(Mantel-Cox) test; control vs. off tetra, ***P < 0.0001; +tetra vs. off tetra, ***P = 0.0006. (c) Haematoxylin 
and eosin (H&E) stained images and Ki67 expression in bone marrow, spleen, and thymus in E2f1−/−; E2f2−/−; 
E2f3TRE/TRE control and E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice 3 weeks after withdrawal of tetracycline. 
Scale bar 100 µm. Representative images from n≥4 mice. (d) Quantification of nucleated cells per 40x field 
www.nature.com/scientificreports/
1 0SCIenTIfIC REPORTS | 7: 9932  | DOI:10.1038/s41598-017-09494-6
obvious requirement to avoid disrupting as many cis-regulatory sequences as possible when choosing the site 
for TRE insertion, as illustrated by the instance of TRE insertion into the Hoxa2 5′ untranslated region, which 
resulted in markedly decreased expression of Hoxa238. In our E2f3 case, TRE insertion into the promoter proved 
highly effective for ectopic E2f3 regulation. However, as indicated by other studies involving ectopic regulation 
of endogenous genes39, each targeted gene will need to be considered individually, most especially when seeking 
rtTA-dependent transcriptional activation.
Expression of the rtTA transcriptional activator in E2f3TRE mice resulted in dramatically elevated and per-
sistent doxycycline dependent ectopic E2f3 expression, which was reversible upon withdrawal of doxycycline. 
Encouragingly, analysis of E2f3’s two neighbouring genes, Mboat1 and Cdkal1, showed them to be unaffected by 
either TRE insertion itself or by the rtTA-dependent upregulation of E2f3, indicating the high precision of E2f3 
gene activation. Of note, the extent of E2f3 induction was around two-fold higher in animals carrying two versus 
one rtTA alleles, further embellishing the tunability of the experimental system. Such doxycycline-dependent 
upregulation resembles that seen in a previous study involving upregulation of a TRE-modified Mlc1 allele and 
an alternative tTA system40.
Conversely, expression of the tTS(kid) or rtTS repressors in E2f3TRE cells and tissues allows for profound, 
doxycycline-dependent, reversible repression of endogenous E2f3. Hence, the combined iterations of these mouse 
models allow for the reversible toggling of endogenous E2f3, up and down, at will, in adult tissues. Of note, in 
both of our E2f3 activation and repression models, E2f3a and E2f3b isoforms are both co-regulated. Hence, in this 
study we cannot attribute any phenotype to a particular E2F3 isoform but rather to total E2F3. However, while we 
acknowledge that E2F3a and E2F3b possess some distinct properties, past studies indicate that each can signifi-
cantly complement for the absence of the other14.
We generated two iterations of the TRE-dependent E2f3 repression system, one (E2f3TRE/TRE; β-actin-tTS) 
repressing E2f3 upon tetracycline withdrawal and the other (E2f3TRE/TRE; Rosa26CAG-rtTS/+) repressing E2f3 upon 
doxycycline addition. Each iteration has its own advantages in terms of rapidity of switching, building up of 
antibiotic reservoirs in bone and teeth over extended antibiotic administration, and minimizing perturbation 
of animals. Either addition of doxycycline to E2f3TRE/TRE; Rosa26CAG-rtTS/+ mice or withdrawal of tetracycline 
from E2f3TRE/TRE; tTS adult mice triggered rapid repression of endogenous E2f3 expression in all tested tissues. 
E2f3TRE/TRE; β-actin-tTS embryos born to mothers maintained on doxycycline were born with Mendelian fre-
quency. However, the embryos of the same genotype developed in mothers deprived of doxycycline failed to 
survive to birth and exhibited the same heart trabeculation deficit as that seen in classical E2f3 knockout embryos. 
Essentially complete E2f3 repression in doxycycline-deprived E2f3TRE/TRE; β-actin-tTS embryos was confirmed 
by analysis of E2F3 protein expression isolated from E2f3TRE/TRE; β-actin-tTS MEFs; E2F3 protein is normally 
expressed in doxycycline-treated E2f3TRE/TRE; β-actin-tTS MEFs but completely absent from doxycycline-deprived 
fibroblasts. Intriguingly, subsequent in vitro addition of doxycycline to MEFs in which E2f3 had been repressed 
throughout development failed to restore E2F3a/b expression (Supplementary Fig. 10), indicating that the E2f3 
gene is permanently silenced if actively repressed through embryogenesis. The mechanism behind this is unclear 
but may involve methylation, as observed elsewhere41.
In adult tissues of E2f3TRE/TRE; β-actin-tTS mice, E2f3 repression was effectively complete and maximal by 1 
week of antibiotic withdrawal, persisting thereafter for as long as tetracycline was withheld. Despite the profound 
repression of E2f3 expression in tetracycline-deprived E2f3TRE/TRE; β-actin-tTS mice, we nonetheless observed 
little impact on proliferation rates of tissues, their architecture and histology, or expression of key E2F1-3 tran-
scriptional targets, such as E2f1, Cdc2 and Cyclin A. This lack of overt phenotype was true even after extended (9 
week) absence of tetracycline. In contrast to our inability to reverse constitutive repression through embryonic 
development, E2f3 repression acutely imposed in adult tissues proved rapidly reversible upon re-administration 
of tetracycline.
While the lack of any phenotype associated with acute E2F3 repression is unsurprising in non-proliferating 
tissues like lung and liver, we also saw no measurable impact in proliferative tissues like intestine, spleen and 
thymus. Equally surprisingly, E2f3 repression had no inhibitory impact on proliferation in tissues regenerating 
after damage – specifically liver after CCl4 injury and intestine after irradiation. Only in the mammary tissue of 
pregnant mice was any impact of acute E2f3 repression evident, which manifested as the significant retardation of 
terminal end bud proliferation and elaboration. This observation may be relevant given the previously published 
potentiating role of E2f3 in experimental mammary cancers of mice11, 12.
Previous reports of tTS-mediated repression of endogenous genes in vivo are largely limited to developmental 
processes42, 43 and utilized doxycycline to inactivate the tTS repressor. One technical issue we encountered with 
the E2f3TRE/TRE; β-actin-tTS system was the tardy onset of repression because of the relatively long biological 
half-life of doxycycline, in part a consequence of developmental accumulation of the antibiotic in somatic res-
ervoirs, most notably bone and teeth. To minimize these problems, we used tetracycline in place of doxycycline 
of view of the bone marrow of E2f1−/−; E2f2−/−; E2f3TRE/TRE control (n = 4) and E2f1−/−; E2f2−/−; E2f3TRE/
TRE; β-actin-tTS (n = 6) mice 3 weeks after withdrawal of tetracycline. (e) Quantification of enteroendocrine 
(Chromogranin A positive), goblet (Alcian blue positive) and Paneth (lysozyme positive) cells per intact 
villus or per intact crypt. In all cases, a total of 30 crypts/villi were counted per mouse from the small intestine 
of E2f1−/−; E2f2−/−; E2f3TRE/TRE control (n = 10(enteroendocrine, goblet), n = 9(Paneth)) and E2f1−/−; 
E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice following the indicated number of weeks (-1 weeks, n = 2), (-2 weeks, 
n = 2(enteroendocrine), n = 3 (goblet, Paneth)), (-3 weeks, n = 5(enteroendocrine), n = 6 (goblet, Paneth)) 
post withdrawal of tetracycline. Mann-Whitney test, control vs. -3 weeks, **P = 0.004 (enteroendocrine), 0.04* 
(goblet), 0.005** (Paneth).
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in all of our tTS repression studies: tetracycline has shorter plasma half-life and proved effective at doses as low 
as 50 mg/L. To circumvent accumulation of the antibiotic, we also reconfigured the tTS(kid) repressor, which is 
inactivated by tetracycline, to the corresponding reverse tetracycline rtTS(kid) variant, which is dependent on the 
drug for its activity. This Rosa26CAG-rtTS strain is ideal for studies in which normal E2F3 expression is needed dur-
ing development, followed by acute E2F3 repression in adult tissues. Furthermore, the new Rosa26CAG-rtTS allele 
exists in a conditional form in which rtTS protein expression is dependent upon Cre activity, allowing repression 
to be manifest only within specific target cell-types or tissues. Similar conditional rtTA alleles are readily available 
for complementary overexpression studies. These further refinements to the experimental system significantly 
enhance its utility and flexibility.
The most plausible explanation for the mildness of the E2f3-repression phenotype is complementation by 
the two other activator E2Fs, E2F1 and E2F23, 5, 7, 33. To investigate this redundancy, we crossed our E2f3TRE/TRE; 
β-actin-tTS mouse into an E2f1−/−; E2f2−/− double knockout background, effectively constraining all activator 
E2F activity to channel through the switchable E2f3TRE allele. In this way, we could evaluate the role of E2F1 and 
E2F2 in compensating for loss of E2F3 function and also gauge the systemic impact of transiently shutting down 
all activator E2F activity on tissues. Systemic blockade of activator E2F1-3 activity triggered dramatic changes in 
differentiation patterns within the small intestine, precipitating a progressive accumulation of enteroendocrine 
Figure 7. The deleterious effects mediated via the repression of activator E2Fs can be reversed within a 
limited time frame. (a) Histogram of total numbers of erythrocytes, leukocytes, and platelets in in E2f1−/−; 
E2f2−/−; E2f3TRE/TRE control (n = 8) and E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice following withdrawal of 
100 mg/L tetracycline for 2 weeks (−2, n = 3), or following removal of tetracycline for 2 weeks followed by re-
administration of tetracycline for the indicated number of weeks (−2/+1, n = 3(erythrocytes), n = 2(leukocytes, 
platelets)) and (−2/+2, n = 5(erythrocytes, platelets), n = 4(leukocytes)), respectively. Error bars, s.e.m. 
Two-tailed t-test; -2weeks vs. −2/+2weeks, **P = 0.001(leukocytes), 0.04*(platelets). (b) Quantification of 
differentiated intestinal cells per villus or crypt (stained as in Fig. 5D) in E2f1−/−; E2f2−/−; E2f3TRE/TRE control 
(n = 10(enteroendocrine, goblet), n = 9(Paneth)) and E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice following 
tetracycline removal for 2 weeks (-2, n = 2(enteroendocrine), n = 3 (goblet, Paneth)), or following removal 
of tetracycline for 2 weeks followed by re-administration of tetracycline for the indicated number of weeks 
(−2/+1, n = 2), (−2/+2, n = 5). Two-tailed t-test; -2weeks vs. −2/+2weeks, *P = 0.04 (goblet), 0.02*(Paneth).
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cells and loss of goblet and Paneth cells, despite having no discernible impact on proliferation. A previous report 
using a β-napthoflavone-driven conditional knock-out strategy similarly suggested that E2F1-3 activities are 
dispensable for adult intestinal proliferation and homeostasis34. However, conditional knockout targeting is 
irreversible, critically dependent upon both the promoter used to drive Cre expression and variable target cell 
recombination efficiencies, and necessarily involves CRE-recombinase–induced DNA damage response44–47, all 
of which are circumvented by the global, reversible E2f3 repression achievable with the E2f3TRE/TRE; β-actin-tTS 
or E2f3TRE/TRE; Rosa26CAG-rtTS system.
Repressing E2f3 in E2f1−/−; E2f2−/− doubly-deficient mice triggered profound collapse of bone marrow, 
together with the onset of leukopenia, thrombocytopenia and progressive erythrocytopenia, with corresponding 
decreases in lymphocyte and myeloid cell populations. These data are consistent with attrition of each blood 
cell type according to its natural lifespan. Mice were moribund following 3 weeks post tetracycline withdrawal. 
However, re-administration of tetracycline two weeks after its withdrawal, at a time of rapidly declining blood 
counts, reversed all pathologies and all animals completely recovered. Such complete rescue of all animals by 
timely restoration of activator E2F activity defines a potentially useful therapeutic window for any treatment 
modality that works by blocking activator E2F activity.
Materials and Methods
Generation of E2f3TRE mice. A vector containing 15 kb of E2f3 genomic sequence was a kind gift from 
Jacqueline Lees. The TRE element was isolated from pTre2 (Clontech) using KpnI and XhoI, and then cloned 
into a KpnI site 500 bp upstream of the E2f3a translation start site along with a LoxP flanked Neomycin resistance 
cassette. No E2f3 sequences were removed or altered at the insertion site, although silent mutations were incor-
porated into the first exons of E2f3a and E2f3b. The final sequences encompassing these mutations is as follows: 
E2f3aWT: cggtggcccaccg/E2f3aMut: TggAggAccTccg; E2f3bWT: cggaaatgcccttacagcagcag/E2f3bMut: cggaaatgc-
cACtTcaAcagcag. Finally, a DTA cassette was added to this vector to allow negative selection in mouse embryonic 
stem cells. This vector was then linearized using NotI and introduced into Sv/129 mouse embryonic stem cells. 
Correct targeting was confirmed by Southern blot, and correctly targeted clones were transiently transfected with 
a plasmid expressing Cre-recombinase in order to remove the conditional Neomycin resistance cassette. The final 
sequence inserted to the KpnI site of mESCs used to generate chimeric animals is below; the residual single LoxP 
site is in bold:
G GT ACCCGGGGAT CCTCTAG ACTCGAGGAA T TCCGATCATAT TCAAT AACCCT TAAT 
ATAACTTCGTATAATGTATGCT ATACG AAGTTATTAGGT CTGAA GAGGAGTTTAC GTCC AGCCAA-
GCTAGCTVTGGCTGC AGGTCGA GTTTACCA CTCCCTAT CAGTGATA GAGAAAAGT GAAAGT CG 
AGT TTA CCAC TCCCTAT CAGTGAT AGAGA AAAGTG AAAG TCGAGTT TACCAC TCCCTA TCAG TGATA-
GAG AAAAG TGAAAG TCGAGTTT ACCACTC CCTAT CAGTGATAGA GAAAAGT GAAAG T CGAGTTT-
AC C AC T  C C C TAT  C AG T G  ATAG AG A  A A AG T G A  A AG T  C G AG T T V TAC C  AC T C C C T AT C 
AGT GATAGA GAAA AGTGAAA GTCGAG TTTAC CACTCCCT ATCAGTGAT AGAGAA AAGTGAAAGTCGAGCTC GGTACC.
Sv/129 mESCs were injected into C57/B6 oocytes and chimeras were evaluated by coat colour. Germline 
transmission was confirmed by PCR and verified by Southern analysis.
Generation of Rosa26CAG-rtTS mice. Overlap extension PCR was used to clone the tetracycline responsive 
domain from rtTA*M2 (Clontech, pTet-on Advanced) to the KRAB-AB silencing domain of the Kid-1 protein 
(SDKid-1) (Clontech, pTet-tTS), creating the chimeric rtTS protein. The full sequence encoding the chimeric 
protein is:
ATGTCTAGACTGGACAAGAGCAAAGTC ATAAACGGCGCT CTGGAATTACTCAATGGAGT-
C G G T A T C G A A G G  C C T G A C G A  C A A G G A A A  C T C G C T C  A A A A G C T G G G  A G T T G A -
G C A G C C T A C C C T  G TA C  T G G C A  C G T G A A  G A A C A A G  C G G G C C  C T G C T C  G AT G C C C -
T G C C A A T C  G A G A T G  C T G G A C A  G G C A T C A  T A C C C A C  T T C T G C C  C C C T  G G A A G 
GCGA GTCATG GCAAGAC TTTCTG CGGAACAA CGCCAAGTCATT CCGCTGTGCT CTCCTCTCA-
CATCGC GACGG GGCTAAA GTGCATC TCGGCA CCCGC CCAACA GAGA AACAG TACGAAAC-
CCTGGA AAATCAG CTCGCGTTC CTGTGTCA GCAAGGCTT CTCCCTG GAGAA CGCACTGT AC 
G C T  C T G T C C G  C C G T G G G C  C AC T T TA C AC T G G  G C T G C G  TAT T G G AG  G A AC AG G  AG C A 
TCA AGTA GCAAAAG AGGAAAGA GAGACACC TACCAC CGATTCTA TGCCCCCAC TTCTGAGA CA 
AG  C A AT T G AG C T G  T T C G A C C G G C  AG G G A G C C G  A AC C T G  C C T T C C  T T T T C  G G C C  T G G 
AACT AATCA TATGT GGCCTG GAGAAAC AGCTAA AGTGCGAAA GCGGCG GGCCAAAA AA 
GAA GAGAAAG CTAGCAGTGTC AGTGAC AT T TGAAGA TGTGGCTGTG CTCT T TAC TCGG-
G AC G AG T G G A A G A AG C T G G AT  C T G T C T C  AG AG A AG C C  T G TAC C G T  G AG G T G A T G C 
TGGAGA AT T A CAGCAA CCTGGC CTCC ATGGCA GGAT TC CTGT T  TACCA AACCA AAG GTG 
ATCTCC CTGTTGCA GCAAGGAG AGGATCCC TGGTAAA.
The SA70b pROSA-CAGGS-attP50/B53-hygro-NLSLacZ vector was obtained from ARTEMIS 
Pharma-ceuticals. A fragment containing the CAGGS promoter and an intron was removed from SA70b and 
cloned into a modified pROSA26 plasmid48, creating the pROSA26CAG-PAS vector. The rtTS cDNA above was 
cloned into pBigT, and then into pROSA26CAG-PAS48 to create the final Rosa26CAG-LSL-rtTS targeting vector. This 
vector was then linearized introduced into mouse embryonic stem cells. Germ-line transmission was confirmed 
by PCR and verified by Southern analysis. A Rosa26CAG-LSL-rtTS/+ male was bred to a Pgk-Cre49 female which 
removed the Lox-stop-lox cassette in the germline to produce Rosa26CAG-rtTS/+ mice, which were then intercrossed 
with E2f3TRE/TRE.
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Mouse maintenance. All animals were kept under SPF conditions, and all experimental procedures 
approved by the University of California, San Francisco Institutional Animal Care and Use Committee or Home 
Office UK guidelines under project licenses to G.I.E. (70/7586, 80/2396) at the University of Cambridge and all 
experimental procedures were conducted in accordance with these guidelines and regulations. Where specified, 
animals were supplied with drinking water containing either tetracycline or doxycycline that was replenished 
twice per week in light-protected bottles. For tTS experiments, tetracycline hydrochloride (Sigma T7660) was 
dissolved at either 50 mg/L (for experiments with E2f3TRE/TRE; β-actin-tTS mice) or 100 mg/L (for experiments 
with E2f1−/−; E2f2−/−; E2f3TRE/TRE; β-actin-tTS mice)and doxycycline hyclate (Sigma D9891) was dissolved at 
100 mg/L. For rtTA and rtTS experiments doxycycline hyclate was dissolved at 2 g/L. In all cases, doxycycline and 
tetracycline were dissolved in water containing 3% sucrose to increase palatability.
Mouse genotyping. Ear biopsies were collected from 2–5 week old mice and digested overnight at 55 °C 
in 10% Chelex 100 Resin (Bio-Rad Catalog #142–1253), 0.1% Tween-20, and 0.25 mg/ml Proteinase K (Sigma 
P8044). Alternatively, tail biopsies were collected (UCSF) and digested overnight at 55 °C in tail lysis buffer 
(50 mM Tris, 50 mM EDTA, 0.5% SDS). gDNA was then precipitated using two volumes of 100% ethanol, washed 
once in 70% ethanol, and resuspended in water.
Genotyping primers for the E2f3TRE allele were designed to span the 300 bp insertion of the 
TRE element .  For ward:  5 ′ -CCAAAACCGAAACT TGCGCTCAAGAC-3 ′  and Reverse :  5 ′ - 
GATACGGTTTACGCGCCAAGGTCCTC-3′. The wild-type allele gives a 424 bp band while a TRE targeted 
allele generates a 865 bp band. Genotyping primers for the β-actin-tTS allele are as follows: Forward: 5′- 
CCCAGAAGCTAGGTGTAGAGCA-3′ Reverse: 5′- GGCGGCATACTATCAGTAGTAGG-3′. General primers 
detecting Rosa26CAG were used to detect Rosa26CAG-rtTS, with primer sequences as follows: Universal forward: 
5′-CTCTGCTGCCTCCTGGCTTCT-3′ Wild-type reverse: 5′-CGAGGCGGATCACAAGCAATA CAG reverse: 
5′ TCAATGGGCGGGGGTCGTT. A typical PCR reaction was performed using GoTaq (Promega) with 1 μl 
of Chelex extracted gDNA following manufacturers’ instructions. The following PCR conditions were applied: 
5 min, 95 °C initial denaturation; 35 cycles of 30 s at 95 °C 30 at, 60 °C and 1.5 min at 72 °C, followed by a final 
5 min at 72 °C. PCR amplification products were analyzed by agarose gel electrophoresis. Jackson Labs (https://
www.jax.org/), provides genotyping information for Rosa26rtTA (Gt(ROSA)26Sortm1(rtTA*M2)Jae), E2f1 knockout 
(E2f1tm1Meg/J), and E2f2 knockout (E2f2tm1Zubi).
Mouse Embryonic Fibroblasts. E2f3TRE/TRE and control wild-type mouse embryonic fibroblasts (MEFs) 
were generated from embryos 13.5 days after fertilization and cultured in DMEM (Thermo Fisher 41966052) sup-
plemented with penicillin-streptomycin (Thermo Fisher, 15140-122), L-glutamine (Thermo Fisher, 25030-024), 
and BGS (Hyclone SH30541.03HI). All experiments were performed between passage 3 and 5. To render cells 
quiescent, MEFs were plated at 8 × 105 cells per 6 cm culture dish in 10% BGS. The next day, MEFs were washed 
twice with PBS and then cultured in media containing 0.1% BGS for 72 hours. To stimulate cell-cycle re-entry, 
quiescent MEFs were stimulated with DMEM containing 20% BGS. For asynchronously cycling experiments, 
MEFs were plated at 3 × 105 cells per 6 cm culture dish in 10% BGS and collected 48 hours later.
qPCR. Total RNA was isolated using TRIzol Reagent (Thermo Fisher, 15596-018) following manufacturers 
instructions. Up to 1 μg of cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit with 
RNase Inhibitor (Thermo Fisher, 4374966) following manufacturers instructions. qPCR reactions were performed 
on a Roche Lightcycler 480 using Lightcycler 480 DNA SYBR Green I mix or Taqman Universal Master Mix II, or 
an Applied Biosystems StepOne using Fast SYBR Green Master Mix (Thermo Fisher, 4385612), following manu-
facturers instructions. Primers used in combination with SYBR Green were E2f3: forward-tacggagtcccgatagtcca, 
reverse-gaccccatcaggagactgg; E2f3a: forward-caaggaccctccagcagag, reverse-agttccagccttcgctttg; Ef3b: 
forward-gctttcggaaatgcccttac, reverse-ggtactgatggccactctcg; E2f1: forward-tgccaagaagtccaagaatca, 
reverse-cttcaagccgcttaccaatc; Cdc2: forward-agaaggtacttacggtgtggt, reverse-gagagatttcccgaattgcagt; CyclinA2: 
forward-gccttcaccattcatgtggat, reverse-ttgctgcgggtaaagagacag; HPRT: forward-ctggtgaaaaggacctctcgaag, 
reverse-ccagtttcactaatgacacaaacg. For Taqman gene expression assays, the following commercial primer/probe 
sets were used: Actin (4352933E, Applied Biosystems), Mboat1 (4331182, Applied Biosystems) and Cdkal1 
(4351372, Applied Biosystems).
Immunoblotting. Animal tissues were ground into powder on liquid nitrogen and proteins extracted in 
buffer containing 1% SDS, 50 mM Tris pH6.8 and 10% Glycerol on ice for 10 minutes. Lysates were boiled for 
10 minutes, followed by sonication (Bioruptor, Diagenode) for 15 minutes on high, with 30 second on/off cycles. 
Total protein (50 µg) was electrophoresed on an SDS-PAGE gel and blotted onto immobilon-P (Millipore) mem-
brane. Membranes were blocked in 5% milk and primary antibodies incubated overnight at 4 °C. Secondary 
antibodies were applied for 1 hour followed by chemiluminescent visualization. Primary antibodies; E2F3 
(Santa-Cruz Biotechnology, sc-878, used at 1:1000), GAPDH (Cell Signaling Technology, 5174 S, used at 1:5000), 
β-Actin (Santa-Cruz Biotechnology, sc-69879, used at 1:5000).
Statistical analysis. Statistical analyses were performed using GraphPad Prism v6.0d (GraphPad Software, 
Inc., San Diego, CA, USA) as indicated with P ≤ 0.05 considered to be statistically significant.
Quantification of mammary gland terminal end buds. To quantify mammary gland terminal end 
buds (TEBs), hematoxylin and eosin stained sections from paraffin embedded number four glands were analyzed. 
Low magnification pictures in proximity to the lymph node were taken. Transversely cut TEBs can be identified 
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by the presence of multiple cell layers and a lack of a ductal lumen. These structures were counted in at least three 
independent biological repeats per genotype by two independent researchers.
Blood cell analysis. Peripheral blood was collected into EDTA or heparin-coated tubes and 40 µl was analyzed 
on a Sysmex haematology analyser. For estimation of total cellularity of bone marrow, the total number of nucleated 
cells was counted per field of view from a hematoxylin and eosin stained section. For the B220, CD3, and Cd11b 
quantifications of cells within the bone marrow, the number of positively stained cells were counted per field of view. 
For both cellularity and cell surface marker stainings in the bone marrow, 3 images per organ/mouse were taken at 
40x magnification and quantified; the mean of 3 raw counts was calculated and represents one data point per graph.
Image acquisition tools and image processing software packages. Immunoblots were developed 
on Fuji RX X-ray film 18 × 24 cm and then scanned on an Epson Perfection V500 Photo flatbed scanner. Images 
were cropped using Adobe Photoshop, but were otherwise unprocessed. Immunohistochemical staining was 
imaged on a Zeiss Axio Imager using the Zeiss AxioVision 4.8 software using the AutoLive setting and interactive 
white balance. Quantification was performed by counting number of cells per field of view for 5 images per organ/
mouse, the mean of 5 raw counts was calculated and represents one data point per graph.
Immunohistochemical analysis. Immunohistochemistry was performed on 4.5 µm sections. Sections were 
de-paraffinized and rehydrated by passing through xylene and a series of ethanols to water. Antigen retrieval was 
performed by boiling in 10 mM citrate buffer (pH 6.0) for 10 minutes. Endogenous peroxidase activity was blocked 
with 0.3% hydrogen peroxide for 30 minutes. Sections were then subject to rabbit VECTASTAIN Elite ABC horse-
radish peroxidase kit following the manufacturers protocols. Sections were developed in DAB for 5 minutes, coun-
terstained in hematoxylin, dehydrated with ethanol, cleared in xylene and mounted in DPX. Primary antibodies; 
Anti-Ki67 (Thermo Scientific, Fremont, CA, USA; clone: SP6; 1:200), Anti-p-H3 (Merck Millipore, Germany; 
06–570: Anti-phospho-Histone H3 (Ser10) Antibody; 1:500), Anti-lysozyme (Life Technologies; A0099), Anti- 
Chromogranin A (Abcam; ab15160), Anti-CD11b antibody (Abcam; ab133357; 1:4000), Anti-CD3 (Themo 
Scientific, RM-9107-R7; prediluted), Anti-CD45R (Thermo Scientific, RA3-6B2, 1:100). Alcian blue staining was 
performed following standard procedures in 1% Alcian blue in 3% acetic acid, pH 2.5.
Tissue regeneration studies. Liver damage was induced in female and male mice (age 8–12 weeks) by a 
single intraperitoneal injection of CCl4 (0.5 ml/Kg in corn oil). Livers were collected 3 days following the CCl4 
injections and proliferative hepatocytes were quantified. Intestinal damage was induced by 14 Gy of gamma irra-
diation from a Cs137 source and small intestine collected 3 days later.
Data Availability. All data generated or analysed during this study are included in this published article (and 
its Supplementary Information files).
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